APC Forum



Vancomycin resistant enterococcus (VRE) – an emerging threat to complex healthcare in Ireland and Australia

Paul Johnson; Deputy Director, Infectious Diseases Dept, Austin Hospital, Victoria, Australia;


Data integration methodologies in the era of multi-omics research

David Gomez Cabrero Lopez, Lecturer, King’s College London, UK;


Professor Paul Johnson is an infectious diseases physician who is currently the deputy director of the Infectious Diseases Department at Austin Health, a university of Melbourne teaching hospital located in Melbourne, Australia. He has research intersts in infection control, mycobacterial infections particularly Mycobacteium ulcerans, and in the pathogenesis and treatment of Staphylococcus aureus infections. Most recently he has established a new research group with Professors Tim Stinear and Ben Howden that is investigating the emergence of hospital acquired Enterococcus faecium colonisation and infection in Australian hospitals (including VRE).  Since 1998 he has been a member of a WHO Technical Advisory Group on Buruli ulcer (Mycobacterium ulcerans infection) and is Director of the WHO Collaborating Centre for Mycobacterium ulcerans (Western Pacific Region) based at VIDRL in the Peter Doherty Institute for Infetion and Immunity in Melbourne. During summer 2017 he is spending sabbatical time with John Cryan and others at the APC as a visiting clinician/scientist to learn about “the micriobiome.

Dr. David Gomez-Cabrero is currently Senior Lecturer at King’s College London, UK, Head of the Translational Bioinformatics Unit at Navarrabiomed and Assistant Professor at the Karolinska Institutet, Sweden. He holds a PhD in Mathematics and has extensive training in quantitative sciences (MSc Statistics, MSc Operations Research). Before landing in Biomedical research he studied two years in Medical School and participated in several Computational Neuroscience related research projects. Dr. Gomez-Cabrero’s research interests are (i) pipeline development in bioinformatic analysis, (ii) developing novel data-integration methodologies and (iii) uncovering disease trajectories. David has been collaborating with clinical researchers investigating Multiple Sclerosis, Rheumatoid arthritis, COPD and Cancer among other diseases.
David has been Work-Package leader in two past European FP7 projects (Synergy-COPD, STATegra) and is currently involved in three active ones (Frailomic, Casym, MultipleMS). From 2011- 2014 he was a member of the distributed national research infrastructure BILS (Bioinformatics Infrastructure for Life Sciences) in charge of RNA-seq and DNA methylation related projects. After joining King’s College London, Dr. Gomez-Cabrero applies data-integration analytical workflows in the context of metagenomics.


Date/Time Date(s) - Aug 29 2017 3:30 pm - 5:00 pm

Loading Map....

Cavanagh Pharmacy Building Room LG51